Rchr
J-GLOBAL ID:201401047338689955   Update date: Oct. 24, 2021

Ueshima Kazuomi

ウエシマ カズオミ | Ueshima Kazuomi
Affiliation and department:
Research field  (2): Tumor diagnostics and therapeutics ,  Gastroenterology
Research keywords  (3): Hepatic arterial infusion chemotherapy ,  Chemotherapy ,  Hepatocellular carcinoma
Research theme for competitive and other funds  (1):
  • 2017 - 2022 ヒト-細菌叢間 化学コミュニケーションの理解と炎症性腸疾患・がん・がん免疫
Papers (107):
  • Yasunori Minami, Masahiro Morita, Hirokazu Chishina, Tomoko Aoki, Masahiro Takita, Satoru Hagiwara, Hiroshi Ida, Kazuomi Ueshima, Naoshi Nishida, Masatoshi Kudo. Can the Entire Ablative Hyperechoic Zone be Regarded as a Necrotic Lesion After Radiofrequency Ablation of the Liver?. Ultrasound in medicine & biology. 2021. 47. 10. 2930-2935
  • Masahiro Morita, Naoshi Nishida, Kazuko Sakai, Tomoko Aoki, Hirokazu Chishina, Masahiro Takita, Hiroshi Ida, Satoru Hagiwara, Yasunori Minami, Kazuomi Ueshima, et al. Immunological Microenvironment Predicts the Survival of the Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Antibody. Liver Cancer. 2021. 10. 4. 380-393
  • Masatoshi Kudo, Yusuke Kawamura, Kiyoshi Hasegawa, Ryosuke Tateishi, Kazuya Kariyama, Shuichiro Shiina, Hidenori Toyoda, Yasuharu Imai, Atsushi Hiraoka, Masafumi Ikeda, et al. Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update. Liver cancer. 2021. 10. 3. 181-223
  • Satoru Hagiwara, Tomohiro Watanabe, Masatoshi Kudo, Kosuke Minaga, Yoriaki Komeda, Ken Kamata, Masatomo Kimura, Hidetoshi Hayashi, Kazuhiko Nakagawa, Kazuomi Ueshima, et al. Clinicopathological analysis of hepatic immune-related adverse events in comparison with autoimmune hepatitis and graft-versus host disease. Scientific reports. 2021. 11. 1. 9242-9242
  • Satoru Hagiwara, Naoshi Nishida, Kazuomi Ueshima, Akihiro Yoshida, Yasunori Minami, Masatoshi Kudo. Comparison of efficacy and safety of entecavir and switching from entecavir to tenofovir alafenamide fumarate in chronic hepatitis B: Long-term effects from a prospective study. Hepatology research : the official journal of the Japan Society of Hepatology. 2021
more...
MISC (396):
  • 青木智子, 上嶋一臣, 工藤正俊. Hepatocellular carcinoma: Multidisciplinary treatment. 消化器外科. 2021. 44. 6
  • 上嶋一臣. Systemic chemotherapy for intermediate-stage hepatocellular carcinoma. 日本臨床腫瘍学会学術集会(CD-ROM). 2021. 18th
  • 上嶋一臣. Role sharing between transcatheter arterial chemoembolization and molecular targeted therapy for hepatocellular carcinoma. 医学と薬学. 2021. 78. 4
  • 青木智子, 上嶋一臣, 工藤正俊. 切除不能肝細胞癌へのレンバチニブ療法におけるFIB-4 index,ALBI scoreの有用性. 日本消化器病学会雑誌(Web). 2021. 118
  • 青木智子, 西田直生志, 上嶋一臣, 祖父江慶太郎, 鶴崎正勝, 工藤正俊. Hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI as an imaging biomarker for WNT/β-catenin mutations for unresectable hepatocellular carcinoma. 肝胆膵. 2021. 83. 2
more...
Books (8):
  • 消化器内科診療レジデントマニュアル
    医学書院 2018 ISBN:9784260035972
  • 肝癌診療Q&A
    中外医学社 2013 ISBN:9784498142121
  • 血管新生阻害薬のベストマネジメント 癌治療と副作用対策, 肝細胞癌(hepatocellular carcinoma).
    金原出版, 東京 2011
  • 肝疾患Review 2010~2011 日本メディカルセンター, 東京, ソラフェニブによる進行肝癌の治療. 第2部 トピックス 肝癌の診断・治療
    2010
  • 肝細胞癌の分子標的治療, ソラフェニブによりCRとなった進行肝細胞癌の2症例.
    アークメディア, 東京 2010
more...
Lectures and oral presentations  (190):
  • Future perspective of molecular targeted therapy for hepatocellular carcinoma
    (17th Japan Association of Molecular Targeted Therapy for HCC 2018)
  • TACE不応の進行肝細胞癌に対するソラフェニブ開始時期の検討.
    (第9回日本肝がん分子標的治療研究会 2014)
  • B-mode ultrasonography versus contrast-enhanced ultrasonography for surveillance of hepatocellular carcinoma: a prospective multicenter randomized controlled trial
    (The 64th Annual Meeting of the American Association for the Study of Liver Disease (AASLD) 2013)
  • Role of oxidative stress and epigenetic alteration on chronic hepatitis C-related human hepatocarcinogenesis
    (The 64th Annual Meeting of the American Association for the Study of Liver Disease (AASLD) 2013)
  • 肝のう胞に対するオレイン酸モノエタノールアミン注入療法の検討
    (第17回日本肝臓学会大会(第21回日本消化器関連学会週間JDDW2013) 2013)
more...
Education (1):
  • 1989 - 1995 Kobe University
Professional career (1):
  • MD,PhD
Work history (4):
  • 2005/01 - 現在 Kindai University Faculty of Medicine
  • 2000/06 - 2004/12 Kobe City General Hospital Department of Gastroenterology
  • 1997/06 - 2000/05 Kobe City General Hospital Department of Emergency Medicine Senior Resident
  • 1995/04 - 1997/05 Kobe City General Hospital Department of Internal Medicine Resident
Committee career (4):
  • 2021/04 - 現在 Japan Oncology Network in Hepatobiliary and Pancreas (JON-HBP) Clinical trial committee member
  • 2019/01 - 現在 Japanese Board of Cancer Therapy Member of educational committee
  • 日本肝癌研究会 肝癌治療効果判定基準作成委員会
  • 日本肝臓学会 肝癌診療ガイドライン改訂委員会 内科系専門委員
Association Membership(s) (8):
Japan Society of Clinical Oncology ,  日本臨床腫瘍学会 ,  日本インターベンショナルラジオロジー学会 ,  JAPANESE ASSOCIATION FOR ACUTE MEDICINE ,  JAPAN GASTROENTEROLOGICAL ENDOSCOPY SOCIETY ,  THE JAPAN SOCIETY OF HEPATOLOGY ,  JAPANESE SOCIETY OF GASTROENTEROLOGY ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page